Iconoclasts topple adaptive myocardial hypertrophy in aortic stenosis

European Heart Journal

Volumn 26, Issue 17, 2005, Pages 1697-1699

  Buermans, Henk P J ^a   Paulus, Walter J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE STENOSIS; CLINICAL FEATURE; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EDITORIAL; HEART DILATATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE WALL; HEART RIGHT VENTRICLE HYPERTROPHY; HEART STRESS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MECHANICAL STRESS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADAPTATION, PHYSIOLOGICAL; AORTIC VALVE STENOSIS; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR;

EID: 24044497614     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi344     Document Type: Editorial

References (10)

1. Grossman W, Jones D, Mc Laurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64.
2. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979;59:679-688.
3. Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJ Jr. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 1980;62:42-48.
4. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis - preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 2005;26:1790-1796. First published on April 28, 2005, doi:10.1093/eurheartj/ehi290.
5. Marban E. Translation, translation, translation. Circulation research in cardiology's new golden age. Circ Res 2005;96:4-5.
6. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the Heart. Circulation 2004;109:1580-1589.
7. Esposito G, Rapacciuolo A, Prasad SVN, Takaoka H, Thomas SA, Koch WJ, Rockman HA. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 2002;105:85-92.
8. Buermans HPJ, Redout EM, Schiel AE, Musters RJP, Zuidwijk M, Eijk PP, van Hardeveld C, Kasanmoentalib S, Visser FC, Yistra B, Simonides WS. Micro-array analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol Genomics 2005; (epub ahead of print).
9. Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, Doring A, Broeckel U, Riegger G, Schunkert H. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003;24:320-328.
10. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 2004;94:1256-1262.